Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-03-06 @ 2:53 AM
Study NCT ID:
NCT03976102
Status:
COMPLETED
Last Update Posted:
2024-01-22
First Post:
2019-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
Sponsor:
Dr. Reddy's Laboratories Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-15
First Submit QC Date:
None
Study First Post Date:
2019-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-28
Results First Submit QC Date:
None
Results First Post Date:
2024-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-16
Last Update Post Date:
2024-01-22
Last Update Post Date Type:
ACTUAL